Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.
Issue link: http://outpatientsurgery.uberflip.com/i/1218927
Message from the President Eric Honroth President, Getinge North America The name of this publication, Managing Risk, clearly reflects the promise embodied in Getinge surgical workflow solutions. These clinical, operational and financial challenges are common to all healthcare institutions in their shared quest to improve patient outcomes, sustain life and improve the quality of living for all those who seek care. The remarkable advancements in surgical practices and technology over the past 20 years have set the stage for even greater achievements in the years ahead as hybrid OR functionality, robotics, minimally invasive surgery, OR integration, and robust infection control initiatives, among others, continue to be refined and broadly implemented. At the same time, it's important to caution that these extraordinary therapeutic and patient safety capabilities often can be constrained by their state of availability at any point in time. That's why in many respects, it's accurate to say that Getinge is in the availability business. For example, as surgical volume grows, high-capacity Getinge 86-Series Washer-Disinfectors help eliminate the risk that critical instrument sets won't be available when and where they are needed. The same holds true with our portfolio of ultrasonic cleaners that can reprocess up to 40 da Vinci instruments per cycle to help ensure their availability for the next scheduled procedure. In the OR, equipment capabilities support a different, but equally important, type of availability. The performance characteristics of our PowerLED II surgical lights inspire confidence that superior technology allows surgeons to fully tap into their personal skill sets and experience. This same principle applies to our Meera mobile operating table's compact and concave table base that allows members of the surgical team to stand as close as possible to the patient which helps reduce muscle fatigue during lengthy procedures. The concept of availability is also central to the purpose of Getinge's Tegris OR integration system that orchestrates immediate access to patient data, and real time/archived images. At the same time, T-DOC instrument traceability and asset management software enables an unprecedented level of account- ability and administrative control. In all of these ways capabilities depend on availability, and Getinge helps make that possible. It's widely agreed that the first robotic surgical procedure was conducted in the late 1980s by a team of surgeons at the Memorial Medical Center in Long Beach, California. Unimation's PUMA 560 robotic system was utilized to achieve more accurate neurosurgical biopsies. The same system was later used to undertake a transurethral resection of the prostate. In an article published in the Annals of The Royal College of Surgeons of England (May 2018), author Tim Lane noted that while early robotic systems had demonstrated the potential of mechanical devices to enhance surgical interventions, subsequent developments designed to facilitate laparoscopic procedures were based on the concept of telepresence. This was explored in a collaboration between the Ames Research Center at NASA and researchers from Stanford. The US military had recognized the potential lifesaving benefits of remotely linking surgeons far from the battlefield to wounded patients via a robotic platform. A number of researchers who worked on this project went on to commercialize their ideas in the private sector. Two competing platforms – ZEUS® from Computer Motion and Intuitive Surgical's da Vinci Surgical System – dominated the early global robotics marketplace. In 1997, The da Vinci system was the first to be used to perform a cholecystectomy. In 1998, da Vinci was used in mitral valve replacement surgery. In 2000, the da Vinci system became the first robotic surgery platform approved by the Federal Drug Administration for general laparoscopic procedures. In 2003, Computer Motion and Intuitive Surgical joined forces focusing future develop- ments on the industry-leading da Vinci platform. Three main types of robotic systems are currently employed in the OR. Active systems autonomously undertake pre-programmed tasks while remaining under the control of the surgeon. Semi-active systems allow for direct surgeon intervention to complement the pre-programmed element of the robotic system. Formal master–slave systems, including da Vinci, are completely dependent on the surgeon. Various media reports predict the continued rapid adoption of robotic technology. According to Reuters, by 2021, one of three surgeries in the United States will be performed with robotic assistance. A July 2019 report by Fortune Business Insights supports this claim, predicting what had been a $1.4 billion market in 2018 will reach $6.87 billion by 2026. The evolution from open surgeries to minimally-invasive robotic-assisted techniques can be attributed to the surgical robot's ability to perform complex procedures with geometrical precision, especially in anatomical areas that are difficult to access by the surgeon's hands. Robotic surgery and the da Vinci system…past, present and future.